ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Shares Pass Above 50-Day Moving Average – Here’s What Happened

ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB)’s share price crossed above its fifty day moving average during trading on Monday . The stock has a fifty day moving average of $88.19 and traded as high as $102.28. ProShares Ultra Nasdaq Biotechnology shares last traded at $99.86, with a volume of 16,137 shares trading hands.

ProShares Ultra Nasdaq Biotechnology Stock Performance

The company has a market cap of $84.18 million, a price-to-earnings ratio of 20.68 and a beta of 1.19. The firm’s 50-day moving average price is $88.51 and its 200 day moving average price is $84.95.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Franklin Resources Inc. bought a new stake in ProShares Ultra Nasdaq Biotechnology in the second quarter valued at about $32,000. Citadel Advisors LLC acquired a new position in shares of ProShares Ultra Nasdaq Biotechnology during the 3rd quarter worth about $307,000. Finally, Kaizen Financial Strategies bought a new stake in shares of ProShares Ultra Nasdaq Biotechnology in the 4th quarter valued at about $424,000.

ProShares Ultra Nasdaq Biotechnology Company Profile

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from the inverse of the return of the Dow Jones United States Basic Materials Index (the Index) for that period. The Fund does not seek to achieve its stated investment objective over a period of time greater than one day.